I am a
Home I AM A Search Login

Papers of the Week


Papers: 25 Jun 2022 - 1 Jul 2022


Pharmacology/Drug Development


2022 Jun 30


Eur Neurol

A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors.

Authors

Alessiani M, Petolicchio B, De Sanctis R, Squitieri M, Di Giambattista R, Puma M, Franzese C, Toscano M, Derchi C-C, Gilliéron E, Viganò A, Di Piero V
Eur Neurol. 2022 Jun 30:1-7.
PMID: 35772386.

Abstract

The objective of this study was to test the superiority of multidisciplinary approach, that is, Short-Term Psychodynamic Psychotherapy (STPP) plus drug of choice, versus monotherapy, that is, OnabotulinumtoxinA (OnaBoNT-A).